Home » Topics » BioWorld Science

BioWorld Science
RSS

University of Kentucky identifies histone demethylase and Wnt signaling inhibitors

Oct. 5, 2021

E-Scape Bio discloses LRRK2 inhibitors

Oct. 5, 2021

Genentech patents new TEAD inhibitors

Oct. 5, 2021

Modulating PPM1E is a therapeutic approach in type 2 diabetes

Oct. 5, 2021

Nobel Prize for Red Hot Chili Pepper and Cool Mint receptors

Oct. 4, 2021

Model illuminates roles of mononuclear phagocyte subsets in renal disease

Oct. 4, 2021

miR-7 recovers motor function after spinal cord injury

Oct. 4, 2021

KATNAL2 gene mutations tied to male infertility

Oct. 4, 2021

GlaxoSmithKline details discovery of new class of BET BD2 inhibitors

Oct. 4, 2021

Preclinical evaluation of novel IDO1 apoenzyme inhibitors

Oct. 4, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.